Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenues:
Total revenues	$ 18,894	$ 23,280	$ 30,886	$ 40,716
Expenses:
Cost of goods sold	4,617	4,411	6,901	8,726
Research and development	4,893	2,329	8,429	4,771
Selling, general and administrative	26,043	20,056	46,740	37,469
(Gain) loss on foreign currency translation	(4,503)	903	(6,486)	(2,935)
Loss on purchase commitments		339		339
Total expenses	39,348	33,553	72,596	57,180
Loss from operations	(20,454)	(10,273)	(41,710)	(16,464)
Other (expense) income:
Interest income, net	516	25	893	28
Interest expense on financing liability	(2,443)		(4,814)
Interest expense on notes	(6,642)	(3,180)	(9,390)	(9,632)
Loss on extinguishment of debt, net		(22,130)		(22,130)
Other expense		35		(241)
Total other expense	(8,569)	(25,250)	(13,311)	(31,975)
Loss before provision for income taxes	(29,023)	(35,523)	(55,021)	(48,439)
Net loss	$ (29,023)	$ (35,523)	$ (55,021)	$ (48,439)
Net loss per share - basic	$ (0.11)	$ (0.14)	$ (0.22)	$ (0.20)
Net loss per share - diluted	$ (0.11)	$ (0.14)	$ (0.22)	$ (0.20)
Shares used to compute net loss per share - basic	253,644	249,295	252,775	247,970
Shares used to compute net loss per share - diluted	253,644	249,295	252,775	247,970
Commercial product sales
Revenues:
Total revenues	$ 12,722	$ 9,976	$ 22,548	$ 18,075
Collaborations and services
Revenues:
Total revenues	5,868	13,304	8,034	22,641
Expenses:
Cost of revenue	8,298	$ 5,515	17,012	$ 8,810
Royalty
Revenues:
Total revenues	$ 304		$ 304